Investor insights
Sectors invested in
Funding rounds participated in
$6.2M sweet spot round size
Most of their 20 investments are in rounds between $33M and $85M
Investor type
Basic info
Industry
Sectors
Date founded
2018
Investments made
Star Therapeutics raised $90M on September 5, 2023
Investors: Qatar Investment Authority, Sofinnova Ventures, Russia technology fund, Redmile Group, Soleus Capital Management, L.P., New Leaf Venture Partners, NYBC Ventures, OrbiMed Advisors, RA Capital Management, L.P. and Westlake Village BioPartners®
Kate Therapeutics raised $51M on June 8, 2023
Investors: UF Innovate | Ventures, Versant Ventures, Osage University Partners (OUP) and Westlake Village BioPartners®
Psioxus Therapeutics raised $30M on January 5, 2023
Investors: Parker Institute for Cancer Immunotherapy, ARCH Venture Partners and Westlake Village BioPartners®
Psioxus Therapeutics raised $30M on January 5, 2023
Investors: Parker Institute for Cancer Immunotherapy, ARCH Venture Partners and Westlake Village BioPartners®
Dantari, Inc. raised $47M on December 8, 2022
Investors: Corner Ventures, Caltech and Westlake Village BioPartners®
ArsenalBio raised $221M on September 6, 2022
Investors: Parker Institute for Cancer Immunotherapy, Kleiner Perkins, SoftBank Investment Advisers, Hitachi Ventures, UCSF, Sixth Street and Westlake Village BioPartners®
Undisclosed raised $10M on May 23, 2022
Investors: Westlake Village BioPartners®
Neuron23 Inc. raised $100M on March 30, 2022
Investors: HBM Partners AG, SoftBank Investment Advisers, Acorn Bioventures, Perceptive Advisors, Surveyor Capital, Kleiner Perkins, Redmile Group and Westlake Village BioPartners®
Electra Therapeutics raised $84M on February 16, 2022
Investors: RA Capital Management, L.P., OrbiMed Advisors, New Leaf Venture Partners, Redmile Group and Westlake Village BioPartners®
Star Therapeutics raised $100M on February 16, 2022
Investors: OrbiMed Advisors, Redmile Group, New Leaf Venture Partners, RA Capital Management, L.P. and Westlake Village BioPartners®